Thompson Trevonne M, Leikin Jerrold B
Department of Emergency Medicine, Division of Medical Toxicology, University of Illinois at Chicago, Chicago, IL, USA,
J Med Toxicol. 2015 Mar;11(1):59-64. doi: 10.1007/s13181-014-0450-z.
We previously reported the financial data for the first 5 years of one of the author's medical toxicology practice. The practice has matured; changes have been made. The practice is increasing its focus on office-based encounters and reducing hospital-based acute care encounters. We report the reimbursement rates and other financial metrics of the current practice. Financial records from October 2009 through September 2013 were reviewed. This is a period of 4 fiscal years and represents the currently available financial data. Charges, payments, and reimbursement rates were recorded according to the type and setting of the medical toxicology encounter: forensic consultations, outpatient clinic encounters, nonpsychiatric inpatient consultations, emergency department (ED) consultations, and inpatient psychiatric consultations. All patients were seen regardless of ability to pay or insurance status. The number of billed Current Procedural Terminology (CPT) codes for office-based encounters increased over the study period; the number of billed CPT codes for inpatient and ED consultations reduced. Office-based encounters demonstrate a higher reimbursement rate and higher payments. In the fiscal year (FY) of 2012, office-based revenue exceeded hospital-based acute care revenue by over $140,000 despite a higher number of billed CPT encounters in acute care settings, and outpatient payments were 2.39 times higher than inpatient, inpatient psychiatry, observation unit, and ED payments combined. The average payment per CPT code was higher for outpatient clinic encounters than inpatient encounters for each fiscal year studied. There was an overall reduction in CPT billing volume between FY 2010 and FY 2013. Despite this, there was an increase in total practice revenue. There was no change in payor mix, practice logistics, or billing/collection service company. In this medical toxicology practice, office-based encounters demonstrate higher reimbursement rates and overall payments compared to inpatient and ED consultations. While consistent with our previous studies, these differences have been accentuated. This study demonstrates the results of changes to the practice--reduced inpatient/ED consultations and increased outpatient encounters. These practice changes resulted in higher overall revenue despite a lower patient volume. In this analysis, the office-based practice of medical toxicology has higher reimbursement rates, nearly 2.5 times higher, when compared to hospital-based acute care consultations.
我们之前报告了一位作者医学毒理学诊疗业务头5年的财务数据。该业务已成熟;做出了一些改变。该业务正日益将重点放在门诊诊疗上,并减少基于医院的急性病护理诊疗。我们报告当前业务的报销率及其他财务指标。对2009年10月至2013年9月的财务记录进行了审查。这是一个4个财年的时间段,代表了当前可得的财务数据。根据医学毒理学诊疗的类型和环境记录收费、付款及报销率:法医会诊、门诊诊所诊疗、非精神科住院会诊、急诊科(ED)会诊及住院精神科会诊。所有患者均接受诊治,无论其支付能力或保险状况如何。在研究期间,基于门诊的现行程序编码(CPT)收费编码数量增加;住院及急诊科会诊的CPT收费编码数量减少。基于门诊的诊疗显示出更高的报销率和更高的付款。在2012财年,尽管急性病护理环境中的CPT诊疗收费编码数量更多,但基于门诊的收入超过基于医院的急性病护理收入逾14万美元,且门诊付款比住院、住院精神科、观察病房及急诊科付款总和高出2.39倍。在所研究的每个财年中,门诊诊所诊疗的每个CPT编码平均付款高于住院诊疗。在2010财年至2013财年期间,CPT计费量总体减少。尽管如此,业务总收入仍有所增加。付款方组合、业务后勤或计费/收款服务公司均未发生变化。在这家医学毒理学业务中,与住院及急诊科会诊相比,基于门诊的诊疗显示出更高的报销率和总体付款。虽然与我们之前的研究一致,但这些差异已更加明显。本研究展示了业务改变的结果——减少住院/急诊科会诊并增加门诊诊疗。尽管患者数量减少,但这些业务改变带来了更高的总收入。在此分析中,与基于医院的急性病护理会诊相比,医学毒理学的门诊业务报销率更高,几乎高出2.5倍。